| 10.5 |
41.8 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 5.8 |
23.4 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 5.5 |
44.4 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 5.5 |
27.5 |
GO:0072015 |
ciliary body morphogenesis(GO:0061073) glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 4.6 |
13.9 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 4.4 |
22.2 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 3.9 |
15.6 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 3.8 |
11.5 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 3.1 |
15.7 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 2.9 |
8.8 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 2.8 |
8.3 |
GO:0021557 |
oculomotor nerve development(GO:0021557) |
| 2.7 |
13.6 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 2.6 |
7.8 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 2.3 |
7.0 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 2.3 |
9.2 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 2.2 |
6.5 |
GO:0060023 |
soft palate development(GO:0060023) |
| 2.0 |
12.2 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 1.9 |
9.6 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 1.9 |
18.8 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 1.8 |
23.7 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 1.8 |
3.6 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 1.8 |
14.5 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 1.8 |
5.3 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 1.7 |
8.6 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 1.7 |
6.7 |
GO:1903898 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 1.6 |
14.5 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.5 |
3.1 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.4 |
2.9 |
GO:0072199 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.3 |
5.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 1.2 |
2.5 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.2 |
8.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 1.2 |
5.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.1 |
3.4 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 1.1 |
8.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.1 |
6.5 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 1.1 |
7.5 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 1.1 |
4.2 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 1.0 |
3.0 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 1.0 |
4.9 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) |
| 1.0 |
3.8 |
GO:0035878 |
nail development(GO:0035878) |
| 0.9 |
11.1 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.9 |
14.5 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.9 |
2.6 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.9 |
6.8 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.8 |
2.5 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.8 |
4.2 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.8 |
12.5 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.8 |
4.0 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.8 |
9.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.8 |
2.3 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.7 |
2.2 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.7 |
7.1 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.7 |
9.9 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.7 |
7.8 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.7 |
2.0 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.6 |
1.9 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.6 |
6.6 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.6 |
6.5 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.6 |
3.0 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.6 |
4.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.6 |
2.2 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.5 |
2.2 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.5 |
2.7 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.5 |
3.8 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.5 |
5.8 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.5 |
3.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.5 |
4.7 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.5 |
10.8 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.5 |
4.6 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.5 |
2.5 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.5 |
4.9 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.5 |
4.8 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.5 |
1.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
5.2 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.5 |
5.1 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.5 |
4.6 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.5 |
3.2 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.4 |
1.3 |
GO:0045358 |
negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.4 |
0.9 |
GO:0003256 |
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
| 0.4 |
0.8 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 |
6.5 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.4 |
7.7 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.4 |
2.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.4 |
1.5 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.4 |
3.7 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.4 |
0.4 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.4 |
1.1 |
GO:0035928 |
mitochondrial RNA 3'-end processing(GO:0000965) RNA 5'-end processing(GO:0000966) rRNA import into mitochondrion(GO:0035928) |
| 0.4 |
1.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.3 |
3.1 |
GO:0097531 |
mast cell migration(GO:0097531) |
| 0.3 |
4.8 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.3 |
1.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.3 |
7.4 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.3 |
6.6 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.3 |
2.5 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.3 |
10.1 |
GO:0021884 |
forebrain neuron development(GO:0021884) |
| 0.3 |
2.0 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.3 |
3.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.3 |
1.2 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
4.3 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.3 |
2.2 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.3 |
1.1 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.3 |
10.0 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.3 |
6.9 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.3 |
5.7 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.2 |
1.7 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
2.8 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.2 |
10.1 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.2 |
7.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 |
2.5 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 |
25.2 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.2 |
11.5 |
GO:0051384 |
response to glucocorticoid(GO:0051384) |
| 0.2 |
1.8 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 |
5.3 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.2 |
0.3 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
0.2 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.2 |
0.7 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.2 |
0.7 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.2 |
4.4 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 |
2.0 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.2 |
7.6 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.2 |
1.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.6 |
GO:0055099 |
regulation of Cdc42 protein signal transduction(GO:0032489) response to high density lipoprotein particle(GO:0055099) platelet dense granule organization(GO:0060155) |
| 0.1 |
0.9 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
2.5 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 |
1.5 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
1.1 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.1 |
2.6 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.1 |
13.8 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) |
| 0.1 |
2.6 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
5.2 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
1.6 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
| 0.1 |
1.0 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
5.1 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.1 |
0.7 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.2 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.1 |
2.9 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
2.3 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.1 |
0.3 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.1 |
2.3 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
4.6 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.1 |
2.9 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
4.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
1.2 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
2.1 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.1 |
1.7 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.6 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
0.2 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.1 |
1.0 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.1 |
3.5 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.1 |
1.3 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 |
1.2 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
1.5 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.1 |
2.0 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
1.0 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
6.4 |
GO:0060348 |
bone development(GO:0060348) |
| 0.0 |
1.3 |
GO:0032330 |
regulation of chondrocyte differentiation(GO:0032330) |
| 0.0 |
0.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
2.9 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
1.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
1.3 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
13.1 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 0.0 |
2.6 |
GO:0032092 |
positive regulation of protein binding(GO:0032092) |
| 0.0 |
1.8 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.0 |
0.1 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 0.0 |
1.4 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
3.3 |
GO:0046034 |
ATP metabolic process(GO:0046034) |
| 0.0 |
1.8 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.0 |
1.6 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.0 |
2.7 |
GO:0006909 |
phagocytosis(GO:0006909) |
| 0.0 |
0.4 |
GO:0006744 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 |
1.8 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
1.5 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
2.9 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.1 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.3 |
GO:0048599 |
oocyte development(GO:0048599) |
| 0.0 |
1.4 |
GO:0001666 |
response to hypoxia(GO:0001666) |
| 0.0 |
0.6 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
1.0 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
